Categoria: Articoli in lingua originale

Bruce Soloway, MD reviewing Heinemann L et al. Lancet 2018 Feb 16. rtCGM might be a valid less-expensive alternative to insulin pumps for type 1 diabetics. Hypoglycemia, a barrier to glycemic control in patients with type 1 diabetes, is more likely to occur in patients with impaired hypoglycemia awareness or past severe hypoglycemia.

Ali S. Raja, MD, MBA, MPH reviewing Kahn PA et al. Ann Intern Med 2017 Dec 26. All emergency medical technicians, from basic to paramedic, should be allowed to use glucagon, and we should be prescribing it from the emergency department. Glucagon remains an important treatment for severe hypoglycemia and can be prescribed

By Amy Orciari Herman Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM The Dietary Approaches to Stop Hypertension (DASH) and Mediterranean diets tied for first place in the “Best Diets Overall” category of U.S. News & World Report‘s annual diet rankings. Top contenders in this category are considered “relatively

Can Oral Insulin Slow Onset of Type 1 Diabetes in High-Risk Patients? Thomas L. Schwenk, MD reviewing Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group. JAMA 2017 Nov 21. Treatment had no effect on diabetes incidence in relatives of patients with type 1 diabetes. In an earlier study, oral

Giving close relatives of people with type 1 diabetes oral insulin did not prevent them from developing diabetes, according to data newly published in the November 21, 2017 issue of the Journal of the American Medical Association. Detailed results of the study, TrialNet Oral Insulin for Prevention of Diabetes in Relatives at

Children who receive higher levels of Vitamin D during infancy and childhood may be significantly at a lower risk of developing islet autoimmunity as well as Type 1 diabetes, according to a study. Type 1 diabetes is a chronic autoimmune disease that is increasing by 3-5 per cent annually worldwide

Denmark’s Novo Nordisk will take aim at Eli Lilly in the growing diabetes market after an advisory panel to the U.S. Food and Drug Administration (FDA) gave the green light to its semaglutide drug. Shares in Novo Nordisk rose almost 3 percent in early trading on Thursday, after the panel

  Alain Joffe, MD, MPH, FAAP reviewing Elder DA et al. J Adolesc Health 2017 Sep 18. Adolescents with newly diagnosed T2DM had a 25% annual decline in beta-cell function despite receiving treatment. Beta-cell function declines over time in adults with type 2 diabetes mellitus (T2DM), but whether this occurs in adolescents is

By Serena GordonHealthDay Reporter TUESDAY, Oct. 10, 2017 (HealthDay News) — Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition — celiac disease, new research suggests. The study found these youngsters appear to face a nearly tripled risk of developing

The U.S. Food and Drug Administration on Friday approved Novo Nordisk’s fast-acting insulin to treat diabetes. The product, known as Fiasp, is designed to help diabetics control post-meal spikes in blood sugar. It is already approved in Canada and Europe. Fiasp, or faster acting insulin aspart, is designed to work